Oramed Pharmaceuticals Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Oramed Pharmaceuticals Inc. now
Current reporting with the operating signal separated from the noise.
Oramed Pharmaceuticals Inc.
The story matters when it changes Oramed Pharmaceuticals Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Oramed Pharmaceuticals Inc. Prices Public Offering of Common Stock for Aggregate Proceeds of $21 Million
Investors are testing whether Oramed Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Oramed Pharmaceuticals Inc. Announces Proposed Public Offering of Common Stock
Investors are testing whether Oramed Pharmaceuticals Inc.’s operating performance supports its strategy and valuation.
Watch next: the filing, cash flow, guidance and capital-expenditure plan.Latest ORMP filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
Oramed Pharmaceuticals Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →